Advancing hepatic augmentation for safer hepatic surgery: insights into portal and hepatic vein embolization strategies - Takeaways - MDSpire

Advancing hepatic augmentation for safer hepatic surgery: insights into portal and hepatic vein embolization strategies

  • By

  • Belkacem Acidi

  • Antony Haddad

  • Jean-Nicolas Vauthey

  • Hop S Tran Cao

  • June 24, 2025

  • 0 min

Share

  • 1

    The future liver remnant (FLR) volume is critical for the safety of major hepatectomy, with insufficient FLR increasing postoperative liver failure risk.

  • 2

    Portal vein embolization (PVE) is a common method to induce FLR hypertrophy, but it may be slow and ineffective for some patients.

  • 3

    Simultaneous portal vein and hepatic vein embolization (PVE/HVE) is emerging as a faster technique for enhancing FLR hypertrophy compared to PVE alone.

  • 4

    PVE has been shown to significantly increase FLR volume, reducing postoperative complications and enhancing the feasibility of curative liver resections.

  • 5

    The choice of embolic materials in PVE has evolved, with N-butyl cyanoacrylate (NBCA) showing superior efficacy for inducing rapid liver hypertrophy.

Original Source(s)

Advancing hepatic augmentation for safer hepatic surgery: insights into portal and hepatic vein embolization strategies

  • by Belkacem Acidi, Antony Haddad, Jean-Nicolas Vauthey, Hop S Tran Cao

  • June 24, 2025

Related Content

Editorial: Novel techniques for colorectal cancer

Oncological safety of portal vein embolization without prior tumour clearance in the future liver remnant followed by one-stage hepatectomy for bilateral colorectal liver metastases

Challenges of decision-making after treatment with immunotherapy in metastatic deficient DNA mismatch repair/microsatellite unstable colorectal cancer